NASDAQ:SGMO - Sangamo Therapeutics SEC Filings & 10K Form

$9.76
+0.45 (+4.83 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
$9.32
Now: $9.76
$9.77
50-Day Range
$8.75
MA: $10.16
$12.09
52-Week Range
$6.26
Now: $9.76
$19.25
Volume1.25 million shs
Average Volume2.07 million shs
Market Capitalization$1.13 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.97

SEC Filings

Sangamo Therapeutics (NASDAQ:SGMO) SEC Filings

DateFilerForm TypeView
06/14/2019
3:02 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/12/2019
4:13 PM
Sangamo Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2019
4:09 PM
Sangamo Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2019
4:08 PM
Ramasastry Saira (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2019
4:07 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2019
4:06 PM
DILLY STEPHEN GEORGE (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2019
4:04 PM
Carey Robert (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2019
4:41 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2019
7:02 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2019
3:34 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/25/2019
3:32 PM
Sangamo Therapeutics (Filer)
Form DEFA14A
View Filing
04/25/2019
3:31 PM
Sangamo Therapeutics (Filer)
Form DEF 14A
View Filing
04/18/2019
5:47 PM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 3/A
View Filing
04/17/2019
3:45 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/16/2019
6:27 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/04/2019
4:03 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/04/2019
4:02 PM
Sangamo Therapeutics (Filer)
Form 424B5
View Filing
04/03/2019
3:08 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/21/2019
4:09 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
6:35 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
7:21 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2019
3:15 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/27/2019
7:20 PM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
7:20 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
7:19 PM
Sangamo Therapeutics (Issuer)
Turner Heather D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
7:18 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
7:17 PM
Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2019
2:29 PM
Sangamo Therapeutics (Filer)
Form CT ORDER
View Filing
02/26/2019
2:22 PM
Sangamo Therapeutics (Filer)
Form CT ORDER
View Filing
02/13/2019
8:47 AM
Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
5:08 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/06/2019
4:27 PM
BlackRock Inc. (Filed by)
Sangamo Therapeutics (Subject)
Form SC 13G/A
View Filing
01/28/2019
4:46 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/28/2019
4:45 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/28/2019
4:45 PM
Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/23/2019
6:06 PM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/16/2019
3:08 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
4:38 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/18/2018
4:35 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/07/2018
6:46 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/03/2018
11:06 AM
Sangamo Therapeutics (Filer)
Form CT ORDER
View Filing
11/26/2018
8:11 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
4:16 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
6:08 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/08/2018
4:09 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/08/2018
3:33 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
4:41 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/06/2018
3:25 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/16/2018
6:25 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/09/2018
4:40 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/04/2018
11:01 AM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/01/2018
3:15 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/18/2018
4:06 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/07/2018
6:18 PM
JEFFS ROGER (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/07/2018
4:45 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/07/2018
3:39 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
3:17 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:37 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/08/2018
3:25 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/07/2018
6:28 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/23/2018
5:06 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/17/2018
3:16 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/09/2018
5:58 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
6:33 PM
Sangamo Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
6:31 PM
Sangamo Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/28/2018
4:23 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/25/2018
12:45 PM
Sangamo Therapeutics (Filer)
Form CT ORDER
View Filing
06/15/2018
6:43 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:30 PM
Sangamo Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:28 PM
Ramasastry Saira (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:27 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:26 PM
Mento Steven J (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:25 PM
JEFFS ROGER (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:24 PM
DILLY STEPHEN GEORGE (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
7:24 PM
Carey Robert (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:17 PM
Sangamo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
06/07/2018
3:06 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/16/2018
5:38 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2018
8:57 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2018
4:38 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/08/2018
6:10 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2018
8:47 PM
Sangamo Therapeutics (Filer)
Form 8-K/A
View Filing
04/26/2018
3:41 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2018
3:38 PM
Sangamo Therapeutics (Filer)
Form 424B5
View Filing
04/24/2018
3:59 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/24/2018
3:55 PM
Sangamo Therapeutics (Filer)
Form 424B5
View Filing
04/24/2018
3:03 PM
Sangamo Therapeutics (Filer)
Form S-3ASR
View Filing
04/24/2018
2:57 PM
Sangamo Therapeutics (Filer)
Form DEFR14A
View Filing
04/24/2018
5:21 AM
Sangamo Therapeutics (Filer)
Form DEFA14A
View Filing
04/24/2018
5:18 AM
Sangamo Therapeutics (Filer)
Form DEF 14A
View Filing
04/24/2018
5:16 AM
Sangamo Therapeutics (Filer)
Form 10-K/A
View Filing
04/18/2018
3:04 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/17/2018
3:16 PM
Herberts Curt A. III (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/17/2018
3:04 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/09/2018
5:43 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/04/2018
3:10 PM
Mento Steven J (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/04/2018
3:09 PM
Herberts Curt A. III (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/23/2018
3:04 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/16/2018
6:41 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2018
7:43 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel